Locations:
Search IconSearch
January 27, 2015/Ophthalmology/News & Insight

Ophthalmology Reimbursement Changes Coming in 2015

Find out how new guidelines may affect your practice

690×380-Reimbursement

Like it or not, significant changes are coming to ophthalmology reimbursement in 2015. Some will affect the amount of money you make; others may even change the way you operate your practice.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

jan2015-subscribe-cqdpulse3

Declining RVUs

The first change that could significantly affect your reimbursement is a devaluation of codes for retinal procedures endorsed by the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC).

“RUC recommended an average cut of about 22 percent in our work RVUs (relative value units) and the Centers for Medicare and Medicaid Services accepted the recommendation,” explains ophthalmologist Rishi Singh, MD, Medical Director of Clinical Systems at Cleveland Clinic.

“Under the Medicare Physician Fee Schedule, reimbursement for cataract surgery has declined by $35. More intricate procedures, such as vitrectomy to repair retinal detachment, have decreased by as much as $417. These procedures are done for medical necessity, so we can’t stop doing them. But we may have to look for cost savings through development of more lean processes,” Dr. Singh says.

From bundles to episodes

Another reimbursement change that is coming in 2015 is a movement from bundled payments to episode-based care payments.

“As of now, surgical payments are bundled so that the physician is paid for the surgery and for any visits over a certain period of time during the post-op period. Under the new payment structure, post-surgery visits will be paid ad hoc on an as-needed basis, so there will be a significant decrease in the surgeon’s initial payment,” Dr. Singh says. “This might not be an issue for surgeons who follow their patient in the post-op period, but those who send their patients to an ancillary provider for post-op care will see a major decrease in their overall reimbursement,” he says.

Advertisement

The Medicare Payment Advisory Commission (MedPAC) is also considering reinstituting a least-costly alternative policy for drug plans. “The new policy would require physicians to prescribe the least expensive drug as a first-line therapy,” Dr. Singh notes. “In order to prescribe a more expensive drug, you’d have to show that the first drug failed as a therapy.” The American Society of Retina Specialists has sent a letter to MedPAC expressing concerns about payers dictating the type of drugs that are used for therapy and offering to assist with alternative methods for cost savings.

It pays to go electronic

Medicare is also getting ready to institute payment cuts for physicians who have not implemented electronic health records (EHRs).

“For some time, physicians have been given incentives to get them to migrate to EHR systems,” says Dr. Singh. “Although the number of physicians adopting EHRs has increased drastically over the last several years, ophthalmologists have been a little slower to adopt.”

In order to avoid the cuts, you must be able to attest to meaningful EHR use (e.g., ordering labs electronically, e-prescribing, offering a secure portal for patients to e-mail the physician). “If you don’t adopt an EHR and attest to meaningful use, you’re subject to payment cuts from Medicare,” Dr. Singh says. “The first cuts, which will begin in 2016, will be 1 to 2 percent, but they’ll increase over time. The good news is that if you do attest in 2015, you can still avoid the cuts for the following years.”

Advertisement

Related Articles

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data shows risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

Closeup of an eye looking at a needle preparing to inject medication into the eyeball
Measuring the Impact of Ongoing Aflibercept Treatment in Diabetic Retinopathy

Study highlights the value of quantitative ultra-widefield angiography

Eye doctor looking into a man's eye
Faricimab Improves Results for Most Patients on Prior Therapy for nAMD

Switching medications may decrease treatment burden and macular fluid

23-EYE-4215262-CQD-Thyroid-eye-disease-tips-general-ophth-hero
Managing Thyroid Eye Disease: Insights for General Ophthalmologists

Interventions abound for active and stable phases of TED

The Featured Image for the post
November 14, 2023/Ophthalmology/News & Insight
The Art of Ophthalmic Imaging

Cole Eye Institute imaging specialists are equal parts technician, artist and diagnostician

23-EYE-4284060-CQD-Myopia-progression-children
Use Caution When Treating Myopia in Children With Intermittent Exotropia

Effect of low-dose atropine and dual-focus contact lenses is unknown in patients with comorbid eye conditions

Ad